Essential Pharma’s Acquisition of Ocular And Postpartum Therapies From Novartis

Lenz & Staehelin advised Essential Pharma in this transaction.Essential Pharma, a portfolio company of Gyrus Capital, has acquired on December 8, 2021, the worldwide rights –…